Length-scale study in deep learning prediction for non-small cell lung cancer brain metastasis
0
🤿
Sign in to get full access
Overview
- Deep learning has the potential to transform digital pathology and clinical practice
- Deep neural networks (DNNs) can outperform human pathologists in image analysis
- However, the complexity of DNNs makes it difficult to explain their decision-making processes
- This can be problematic in pathology, as the ability to interpret the underlying features used by the DNN is important for gaining physiological insights
Plain English Explanation
Deep learning, a type of artificial intelligence, has the potential to significantly impact how digital pathology is used in clinical practice. Recent studies have shown that deep neural networks (DNNs), a type of deep learning model, can analyze digital microscopic images and outperform human pathologists in certain tasks. This is an exciting development, as it could lead to more accurate and efficient diagnosis and treatment planning.
However, a key challenge with these powerful DNN models is that they can be very complex, making it difficult to understand the specific features they are using to make their predictions. This lack of explainability is particularly problematic in the field of pathology, where being able to interpret the underlying features used by the DNN is important for gaining insights into the biological mechanisms of disease.
To address this, the researchers in this study developed a novel method to better understand the predictive features that a DNN uses when analyzing digital microscopic images. They applied this method to a specific case study of using a DNN to predict brain metastasis in lung cancer patients based on biopsy slides.
Technical Explanation
The researchers sought to understand the role of image resolution and tissue scale in the DNN's predictive performance. They developed a novel method to study the length-scale of the features that the DNN uses to make its predictions.
The researchers applied this method to a DNN trained to predict brain metastasis in lung cancer patients based on H&E-stained whole slide images of biopsy samples. Their analysis revealed that the DNN's predictive power was strongly influenced by both the cellular-scale (resolution) and tissue-scale features in the images.
At the cellular scale, the DNN's predictive power increased as the resolvable feature length decreased, with the DNN performing best when it could detect features smaller than 5 microns. At the tissue scale, the DNN used more macro-scale features related to tissue organization and architecture, and its performance was optimized when assessing visual fields larger than 41 microns.
This study is the first to demonstrate the specific length-scale requirements necessary for a DNN to learn effectively from digital whole slide images in the context of pathology. These insights into the DNN's decision-making process can be used to improve the interpretability and explainability of the model, which is crucial for the broader clinical adoption of these powerful tools.
Critical Analysis
The researchers have taken an important step in addressing the lack of explainability in deep learning-based pathology analysis. By developing a novel method to study the DNN's predictive features, they have provided valuable insights into the specific length-scales that the model relies on to make its predictions.
However, it is important to note that this study was focused on a single case example of brain metastasis prediction from lung cancer biopsy slides. Additional research is needed to determine if these findings hold true for other pathological conditions and tissue types.
Furthermore, the researchers did not address the potential limitations of their method, such as the computational resources required to perform the analysis or the potential for bias in the manual feature annotations used to train the model. It would be valuable for future studies to explore these aspects in more detail.
Overall, this study represents an important step towards improving the interpretability and explainability of deep learning models in digital pathology. By continuing to explore these issues, researchers can help to increase the clinical adoption and impact of these powerful tools.
Conclusion
This study presents a novel method for understanding the predictive features used by deep neural networks in digital pathology analysis. The researchers applied this method to a case study of brain metastasis prediction from lung cancer biopsy slides, and found that the DNN's performance was strongly influenced by both cellular-scale and tissue-scale features in the images.
These insights into the DNN's decision-making process are crucial for improving the interpretability and explainability of these powerful models, which is essential for their broader adoption in clinical practice. By continuing to explore these issues, researchers can help to unlock the full potential of deep learning-assisted digital pathology to improve patient outcomes.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
🤿
0
Length-scale study in deep learning prediction for non-small cell lung cancer brain metastasis
Haowen Zhou (Siyu), Steven (Siyu), Lin, Mark Watson, Cory T. Bernadt, Oumeng Zhang, Ramaswamy Govindan, Richard J. Cote, Changhuei Yang
Deep learning assisted digital pathology has the potential to impact clinical practice in significant ways. In recent studies, deep neural network (DNN) enabled analysis outperforms human pathologists. Increasing sizes and complexity of the DNN architecture generally improves performance at the cost of DNN's explainability. For pathology, this lack of DNN explainability is particularly problematic as it hinders the broader clinical interpretation of the pathology features that may provide physiological disease insights. To better assess the features that DNN uses in developing predictive algorithms to interpret digital microscopic images, we sought to understand the role of resolution and tissue scale and here describe a novel method for studying the predictive feature length-scale that underpins a DNN's predictive power. We applied the method to study a DNN's predictive capability in the case example of brain metastasis prediction from early-stage non-small-cell lung cancer biopsy slides. The study highlights the DNN attention in the brain metastasis prediction targeting both cellular scale (resolution) and tissue scale features on H&E-stained histological whole slide images. At the cellular scale, we see that DNN's predictive power is progressively increased at higher resolution (i.e., lower resolvable feature length) and is largely lost when the resolvable feature length is longer than 5 microns. In addition, DNN uses more macro-scale features (maximal feature length) associated with tissue organization/architecture and is optimized when assessing visual fields larger than 41 microns. This study for the first time demonstrates the length-scale requirements necessary for optimal DNN learning on digital whole slide images.
Read more6/4/2024
0
Impact of Stain Variation and Color Normalization for Prognostic Predictions in Pathology
Siyu (Steven), Lin, Haowen Zhou, Richard J. Cote, Mark Watson, Ramaswamy Govindan, Changhuei Yang
In recent years, deep neural networks (DNNs) have demonstrated remarkable performance in pathology applications, potentially even outperforming expert pathologists due to their ability to learn subtle features from large datasets. One complication in preparing digital pathology datasets for DNN tasks is variation in tinctorial qualities. A common way to address this is to perform stain normalization on the images. In this study, we show that a well-trained DNN model trained on one batch of histological slides failed to generalize to another batch prepared at a different time from the same tissue blocks, even when stain normalization methods were applied. This study used sample data from a previously reported DNN that was able to identify patients with early stage non-small cell lung cancer (NSCLC) whose tumors did and did not metastasize, with high accuracy, based on training and then testing of digital images from H&E stained primary tumor tissue sections processed at the same time. In this study we obtained a new series of histologic slides from the adjacent recuts of same tissue blocks processed in the same lab but at a different time. We found that the DNN trained on the either batch of slides/images was unable to generalize and failed to predict progression in the other batch of slides/images (AUC_cross-batch = 0.52 - 0.53 compared to AUC_same-batch = 0.74 - 0.81). The failure to generalize did not improve even when the tinctorial difference correction were made through either traditional color-tuning or stain normalization with the help of a Cycle Generative Adversarial Network (CycleGAN) process. This highlights the need to develop an entirely new way to process and collect consistent microscopy images from histologic slides that can be used to both train and allow for the general application of predictive DNN algorithms.
Read more9/16/2024
0
Exploring Explainable AI Techniques for Improved Interpretability in Lung and Colon Cancer Classification
Mukaffi Bin Moin, Fatema Tuj Johora Faria, Swarnajit Saha, Busra Kamal Rafa, Mohammad Shafiul Alam
Lung and colon cancer are serious worldwide health challenges that require early and precise identification to reduce mortality risks. However, diagnosis, which is mostly dependent on histopathologists' competence, presents difficulties and hazards when expertise is insufficient. While diagnostic methods like imaging and blood markers contribute to early detection, histopathology remains the gold standard, although time-consuming and vulnerable to inter-observer mistakes. Limited access to high-end technology further limits patients' ability to receive immediate medical care and diagnosis. Recent advances in deep learning have generated interest in its application to medical imaging analysis, specifically the use of histopathological images to diagnose lung and colon cancer. The goal of this investigation is to use and adapt existing pre-trained CNN-based models, such as Xception, DenseNet201, ResNet101, InceptionV3, DenseNet121, DenseNet169, ResNet152, and InceptionResNetV2, to enhance classification through better augmentation strategies. The results show tremendous progress, with all eight models reaching impressive accuracy ranging from 97% to 99%. Furthermore, attention visualization techniques such as GradCAM, GradCAM++, ScoreCAM, Faster Score-CAM, and LayerCAM, as well as Vanilla Saliency and SmoothGrad, are used to provide insights into the models' classification decisions, thereby improving interpretability and understanding of malignant and benign image classification.
Read more5/15/2024
🤖
0
Beyond Multiple Instance Learning: Full Resolution All-In-Memory End-To-End Pathology Slide Modeling
Gabriele Campanella, Eugene Fluder, Jennifer Zeng, Chad Vanderbilt, Thomas J. Fuchs
Artificial Intelligence (AI) has great potential to improve health outcomes by training systems on vast digitized clinical datasets. Computational Pathology, with its massive amounts of microscopy image data and impact on diagnostics and biomarkers, is at the forefront of this development. Gigapixel pathology slides pose a unique challenge due to their enormous size and are usually divided into tens of thousands of smaller tiles for analysis. This results in a discontinuity in the machine learning process by separating the training of tile-level encoders from slide-level aggregators and the need to adopt weakly supervised learning strategies. Training models from entire pathology slides end-to-end has been largely unexplored due to its computational challenges. To overcome this problem, we propose a novel approach to jointly train both a tile encoder and a slide-aggregator fully in memory and end-to-end at high-resolution, bridging the gap between input and slide-level supervision. While more computationally expensive, detailed quantitative validation shows promise for large-scale pre-training and fine-tuning of pathology foundation models.
Read more5/24/2024